SCHEMBL31658294

SCHEMBL31658294

COc1ccc2c(c1)N(Cc1ccccc1)S(=O)(=O)c1cc(OC)c(OC)cc1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.49
▸ ELANE P08246 1/20 0.45
▸ MAPT P10636 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ RXFP1 Q9HBX9 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ HCRTR1 O43613 1/20 0.42
▸ HCRTR2 O43614 1/20 0.42
▸ RAB9A P51151 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ PAX8 Q06710 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ HSD11B1 P28845 1/20 0.40
▸ NTRK1 P04629 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31658275 0.91 GAA (0.49) GAAELANEMAPTALDH1A1TDP1
SCHEMBL26767752 0.90 GAA (0.53) GAAELANEMAPTALDH1A1TDP1
SCHEMBL31658268 0.89 CHRM5 (0.45) GAAELANERXFP1TP53HCRTR1
SCHEMBL31658296 0.89 CA12 (0.46) GAAMAPTRXFP1HCRTR1HCRTR2
SCHEMBL31658259 0.89 CA12 (0.42) GAAELANEMAPTALDH1A1LMNA
SCHEMBL26767795 0.86 GAA (0.49) GAAELANEMAPTALDH1A1TDP1
SCHEMBL31658257 0.85 GAA (0.42) GAAELANEMAPTALDH1A1RXFP1
SCHEMBL31662439 0.84 CA12 (0.46) GAAMAPTTDP1RXFP1HCRTR1
SCHEMBL31662739 0.83 HCRTR1 (0.41) GAAMAPTRXFP1HCRTR1HCRTR2
SCHEMBL31658253 0.81 GAA (0.46) GAAMAPTALDH1A1TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025149586-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF FATTY LIVER DISEASE SCANDIEDGE THERAPEUTICS AB (SE) 2025-07-17 — — WO disclosed
EP-4585216-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF FATTY LIVER DISEASE ScandiEdge Therapeutics AB (SE) 2025-07-16 — — EP disclosed
Send feedback